Stop Developing Drugs for the Cancer That Killed My Mother
October 31, 2014
October 31, 2014 Illustration by Shout
Funding drug development for rare cancers can hurt patients.
Scientists need to abandon the assumption that every medical challenge must be overcome by a direct attack.
Click here to continue reading.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.